InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,584.54
(
-0.88%
)
US TECH 100
19,691.60
(
0.07%
)
Dow Jones
39,753.75
(
0.08%
)
Brent Oil
85.36
(
0.29%
)
Bitcoin
57,151.19
(
-0.35%
)
Post# of 4867
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Tha Part Time Er

Send PM Follow Ignore
Followers 91
Posts 3296
Boards Moderated 0
Alias Born 10/18/2010

Tha Part Time Er

Re: north40000 post# 3701

Tuesday, 05/05/2020 2:40:17 PM

Tuesday, May 05, 2020 2:40:17 PM

Post# of 4867
12:31 PM ET: Remdesivir Looks Set for Japan Approval Gilead Sciences (NASDAQ:GILD)' antiviral drug remdesivir may be approved in Japan for domestic COVID-19 patients when the health ministry’s review board is held on Thursday, Japanese Health Minister Katsunobu Kato said
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent GILD News
More GILD News
InvestorsHub NewsWire

FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM

ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM

Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM

Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

Start posting your company's news
Only $200 per official company press release!